Inventiva Pharma
Nasdaq IVA · Daix, France
Works in GI & liver · Metabolic & endocrine
Inventiva Pharma is a clinical trial sponsor based in Daix, France, listed as Nasdaq IVA. It has 1 active clinical trial with 1,000 planned participants, in GI & liver and Metabolic & endocrine. Since 2021 it has completed 2 trials and stopped 0 early.
Trial track record · since 2021
Financials · Nasdaq IVA
Pipeline · 1 active trial
| Stage | Trial | Status |
|---|---|---|
Questions about Inventiva Pharma
Inventiva Pharma is lead sponsor of 1 active clinical trial on ClinicalTrials.gov, with 1,000 planned participants, in GI & liver, Metabolic & endocrine. Since 2021 it has completed 2 trials and stopped 0 early.
Inventiva Pharma is based in Daix, France and is listed as Nasdaq IVA. The address is the one on its SEC filings, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Inventiva Pharma; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-09-09.
Approve Suite is not affiliated with Inventiva Pharma.
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.